Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.
AptarGroup, Inc. (NYSE: ATR) generates news across drug delivery, digital health and consumer dispensing technologies. As a global company serving pharmaceutical, beauty, food, beverage, personal care and home care markets, its announcements often highlight new delivery systems, clinical collaborations, acquisitions and financial updates that are relevant to investors and industry observers.
Recent news has featured Aptar Pharma’s nasal and ophthalmic platforms, such as LuerVax and Spray Divider being used in a Phase II clinical trial of an intranasal COVID-19 vaccine candidate, and Bidose liquid nasal spray systems delivering an FDA-approved treatment for paroxysmal supraventricular tachycardia. The company also reports on developments in eye care, including its Beat the Blink technology and preservative-free multidose dispensers, as well as broader portfolios of ophthalmic solutions.
Aptar’s Digital Health division appears frequently in updates related to connected health tools and data-driven care. Examples include the integration of the Migraine Buddy app with biometric data from wearable devices and FDA 510(k) clearance for HeroTracker Sense, a connected add-on for metered-dose inhalers within a respiratory disease management platform.
Investors following ATR news will also find earnings releases, segment performance commentary, conference participation announcements and information on capital markets activity, such as senior notes offerings. This news page brings together these items so readers can review Aptar’s latest product milestones, partnerships, digital health initiatives and financial communications in one place.
AptarGroup, Inc. (NYSE: ATR) has announced its plan to acquire 80% of Weihai Hengyu Medical Products Co., Ltd., a notable Chinese manufacturer of elastomeric and plastic components for injectable drug delivery. This strategic investment aims to enhance Aptar's capabilities in high-growth markets like China while responding to local market demands. The acquisition is expected to close by the end of Q3 2021 and is not projected to materially impact adjusted earnings per share for 2021 or 2022. This move aligns with Aptar's ongoing strategy to strengthen its position in the injectable drug delivery market.
AptarGroup, Inc. (NYSE: ATR) has acquired a majority stake in Voluntis, acquiring approximately 64.6% of its share capital at €8.70 per share. The share purchase agreement was signed on July 22, 2021, following exclusive negotiations since June 21, 2021. The acquisition is subject to customary conditions and expected to complete by the end of Q3 2021. Following the acquisition, Aptar plans a mandatory cash tender offer for remaining Voluntis shares at the same price, pending regulatory approval. Voluntis’ board has appointed an independent expert to review the offer's financial terms.
AptarGroup, Inc. (NYSE: ATR) has announced a quarterly cash dividend of $0.38 per share, payable on August 25, 2021, to stockholders of record as of August 4, 2021. The company, a leader in drug delivery and consumer product dispensing solutions, will also hold a conference call on July 30, 2021 at 8:00 a.m. Central Time to discuss its second quarter results for 2021. Interested parties can access the live call via a webcast on their Investors page.
AptarGroup (NYSE: ATR) and YAT have announced a strategic collaboration to develop innovative skincare products. This partnership combines YAT's consumer-centric approach and market insights with Aptar’s advanced packaging solutions. By leveraging their combined expertise, they aim to enhance product offerings in China, catering to specific consumer skincare needs. Aptar has also made a strategic equity investment in YAT to further support the development of tailored solutions in this fast-growing market.
AptarGroup, Inc. (NYSE: ATR) has entered exclusive negotiations to potentially acquire all outstanding shares of Voluntis (ENXTPA: ALVTX) for €8.70 per share, valuing the company at approximately €78.8 million ($95.3 million). The acquisition aims to enhance Aptar's digital health portfolio by integrating Voluntis's digital therapeutic solutions, which support chronic disease management. This strategic move aligns with Aptar's focus on expanding digital capabilities and is expected to have a dilutive impact of $0.01 to $0.02 per share for FY 2022.
Summary not available.
AptarGroup, Inc. (NYSE:ATR) has unveiled its first fully recyclable mono-material pump named Future, aimed at the beauty and personal care markets. Made exclusively from polyethylene (PE), the pump is designed to enhance recycling processes and has received certifications from Cyclos-HTP and RecyClass. This innovation aligns with Aptar's commitment to sustainable practices and a circular economy. Future also features an advanced locking mechanism and is compliant with e-commerce standards. The launch will be showcased at the ChangeNow 2021 Global Summit on May 27.
AptarGroup (NYSE: ATR) has appointed Candace Matthews to its Board of Directors. With over 30 years of experience in healthcare, cosmetics, and consumer products, Matthews has previously held leadership roles at Amway and L’Oréal. Her expertise adds significant value to Aptar’s operations, aligning with the company's focus on innovation in drug delivery and consumer products. Currently, 45% of Aptar's Board is female, and all committees are chaired by women, highlighting the company's commitment to diversity.
AptarGroup, Inc. (NYSE: ATR) has been recognized in 3BL Media’s 100 Best Corporate Citizens ranking, highlighting its leadership and transparency in environmental, social, and governance (ESG) practices. The ranking evaluates major U.S. companies based on various ESG criteria. Aptar emphasizes its commitment to sustainability, aligning with United Nations Global Compact principles. President and CEO Stephan B. Tanda expressed pride in their corporate citizenship efforts, while Vice President Beth Holland noted ongoing commitments to stakeholder communication and global sustainability goals.
AptarGroup, Inc. (NYSE:ATR) announced a 5% price increase for its beauty, personal care, and home care products, effective June 1, 2021. This decision responds to sustained cost inflation on non-raw material inputs, including freight, energy, and labor. Marc Prieur, President of Aptar Beauty + Home, emphasized the necessity of these adjustments due to unprecedented cost increases and efforts to ensure safe production amid the COVID-19 pandemic. Sales representatives will provide customers with more details on the price changes.